Diagnostic Equipment · Burnaby, Canada · Founded 2007 · Privately Held (backing)
Developer of medical devices designed to help in the diagnosis and treatment of atrial fibrillation. Kardium is based in Burnaby, Canada and was founded in 2007. It has raised $575 million across 3 recorded rounds; the latest was a $104 million later-stage round in May 2024.
PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$575.2M
Last round
Later Stage VC
May 2024
No prints on record
No secondary trades in Kardium shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Kardium stock.
